Revvity ROE 2010-2023 | RVTY
Current and historical return on equity (ROE) values for Revvity (RVTY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Revvity ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2023-12-31 | $0.69B | $7.87B | 8.81% |
| 2023-09-30 | $0.74B | $7.69B | 9.58% |
| 2023-06-30 | $0.82B | $7.87B | 10.78% |
| 2023-03-31 | $0.96B | $8.03B | 12.97% |
| 2022-12-31 | $0.57B | $7.38B | 7.90% |
| 2022-09-30 | $0.63B | $7.07B | 8.84% |
| 2022-06-30 | $0.67B | $7.17B | 9.48% |
| 2022-03-31 | $0.74B | $7.19B | 11.61% |
| 2021-12-31 | $0.94B | $7.14B | 16.88% |
| 2021-09-30 | $1.13B | $6.96B | 23.93% |
| 2021-06-30 | $1.18B | $4.24B | 31.09% |
| 2021-03-31 | $1.07B | $4.00B | 30.80% |
| 2020-12-31 | $0.73B | $3.74B | 22.94% |
| 2020-09-30 | $0.41B | $3.23B | 14.03% |
| 2020-06-30 | $0.30B | $2.97B | 10.49% |
| 2020-03-31 | $0.23B | $2.76B | 8.26% |
| 2019-12-31 | $0.23B | $2.81B | 8.39% |
| 2019-09-30 | $0.23B | $2.71B | 8.80% |
| 2019-06-30 | $0.25B | $2.71B | 9.60% |
| 2019-03-31 | $0.25B | $2.64B | 9.58% |
| 2018-12-31 | $0.24B | $2.59B | 9.31% |
| 2018-09-30 | $0.13B | $2.57B | 4.97% |
| 2018-06-30 | $0.14B | $2.52B | 5.54% |
| 2018-03-31 | $0.28B | $2.56B | 11.16% |
| 2017-12-31 | $0.29B | $2.50B | 12.10% |
| 2017-09-30 | $0.40B | $2.54B | 17.09% |
| 2017-06-30 | $0.37B | $2.44B | 16.38% |
| 2017-03-31 | $0.23B | $2.21B | 10.53% |
| 2016-12-31 | $0.23B | $2.15B | 11.11% |
| 2016-09-30 | $0.24B | $2.14B | 11.31% |
| 2016-06-30 | $0.23B | $2.09B | 11.28% |
| 2016-03-31 | $0.22B | $2.05B | 10.51% |
| 2015-12-31 | $0.21B | $2.11B | 10.16% |
| 2015-09-30 | $0.18B | $2.05B | 8.46% |
| 2015-06-30 | $0.16B | $2.12B | 7.82% |
| 2015-03-31 | $0.16B | $2.06B | 7.93% |
| 2014-12-31 | $0.16B | $2.04B | 7.67% |
| 2014-09-30 | $0.19B | $2.06B | 9.48% |
| 2014-06-30 | $0.19B | $2.06B | 9.55% |
| 2014-03-31 | $0.17B | $2.03B | 8.66% |
| 2013-12-31 | $0.17B | $1.99B | 8.78% |
| 2013-09-30 | $0.08B | $1.92B | 4.45% |
| 2013-06-30 | $0.07B | $1.86B | 3.91% |
| 2013-03-31 | $0.08B | $1.83B | 4.21% |
| 2012-12-31 | $0.07B | $1.94B | 3.71% |
| 2012-09-30 | $0.00B | $1.94B | 0.16% |
| 2012-06-30 | $0.01B | $1.89B | 0.53% |
| 2012-03-31 | $0.01B | $1.88B | 0.31% |
| 2011-12-31 | $0.01B | $1.84B | 0.42% |
| 2011-09-30 | $0.39B | $1.95B | 20.07% |
| 2011-06-30 | $0.36B | $1.96B | 19.42% |
| 2011-03-31 | $0.39B | $1.91B | 21.83% |
| 2010-12-31 | $0.39B | $1.93B | 22.64% |
| 2010-09-30 | $0.13B | $1.71B | 7.93% |
| 2010-06-30 | $0.13B | $1.64B | 8.12% |
| 2010-03-31 | $0.10B | $1.63B | 5.97% |
| 2009-12-31 | $0.08B | $1.63B | 5.26% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.539B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.869B | 15.67 |
| Cencora (COR) | United States | $48.051B | 19.18 |
| ICON (ICLR) | Ireland | $25.434B | 24.01 |
| DiDi Global (DIDIY) | China | $24.400B | 0.00 |
| Avantor (AVTR) | United States | $16.238B | 23.94 |
| Viatris (VTRS) | United States | $13.880B | 3.96 |
| CochLear (CHEOY) | $13.776B | 0.00 | |
| Medpace Holdings (MEDP) | United States | $12.267B | 40.36 |
| Charles River Laboratories (CRL) | United States | $11.798B | 21.50 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.548B | 0.00 |
| Natera (NTRA) | United States | $11.205B | 0.00 |
| Solventum (SOLV) | United States | $11.115B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.282B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.886B | 51.45 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 19.99 |
| Organon (OGN) | United States | $4.771B | 4.59 |
| Doximity (DOCS) | United States | $4.444B | 33.08 |
| PACS (PACS) | United States | $3.713B | 0.00 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Surgery Partners (SGRY) | United States | $3.120B | 28.88 |
| Progyny (PGNY) | United States | $3.079B | 51.68 |
| GoodRx Holdings (GDRX) | United States | $2.840B | 143.80 |
| Life Times (LTH) | United States | $2.783B | 30.76 |
| Premier (PINC) | United States | $2.511B | 9.19 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.164B | 7.00 |
| Agilon Health (AGL) | United States | $2.055B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.811B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| NovoCure (NVCR) | Jersey | $1.360B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.331B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $0.985B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.760B | 7.86 |
| Embecta (EMBC) | United States | $0.594B | 3.92 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.503B | 45.59 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
| LifeMD (LFMD) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.434B | 0.00 |
| Beauty Health (SKIN) | United States | $0.400B | 0.00 |
| CareDx (CDNA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| MultiPlan (MPLN) | United States | $0.371B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.349B | 0.00 |
| ModivCare (MODV) | United States | $0.335B | 4.44 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.289B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| Biodesix (BDSX) | United States | $0.142B | 0.00 |
| So-Young (SY) | China | $0.125B | 41.83 |
| Oncology Institute (TOI) | United States | $0.085B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |